Wordt geladen...
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
BACKGROUND: Treatment of central nervous system relapse in adult acute lymphoblastic leukemia is a challenge and outcome is poor. Liposomal cytarabine has a prolonged half-life and, given intrathecally, has produced high response rates in patients with central nervous system relapse of non-Hodgkin...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Ferrata Storti Foundation
2011
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3031691/ https://ncbi.nlm.nih.gov/pubmed/20952517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.028092 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|